Johnson & Johnson (J&J) is seeking European regulatory approval for its two-stage experimental Ebola vaccine. J&J filed requests with the European Medicines Agency for its treatment of the common the Democratic Republic of the Congo strain, alongside supporting data from over 10 studies testing the drug in adults and children. It comes after Merck's single-shot Ebola vaccine secured approval in October and will be dispensed alongside J&J's vaccine, which is set to be introduced in Zaire this month.
Johnson & Johnson (J&J) is seeking European regulatory approval for its two-stage experimental Ebola vaccine. J&J filed requests with the European Medicines Agency for its treatment of the common Zaire strain, alongside supporting data from over 10 studies testing the drug in adults and children. It comes after Merck's single-shot Ebola vaccine secured approval in October and will be dispensed alongside J&J's vaccine, which is set to be introduced in the Democratic Republic of the Congo this month.